| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/23/2006 | US20060040958 Antiproliferative agents; anticancer agents; antiinflammatroy agents; Alzheimer's disease; viricides; fungicides |
| 02/23/2006 | US20060040957 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 02/23/2006 | US20060040944 5-Aza-7-deazapurine derivatives for treating Flaviviridae |
| 02/23/2006 | US20060040943 3-Furanyl analogs of toxoflavine as kinase inhibitors |
| 02/23/2006 | US20060040942 Antiinflammatory agents; autoimmune disease |
| 02/23/2006 | US20060040941 7-Aminoimidazotriazones |
| 02/23/2006 | US20060040940 Imidazopyridines pyrimidines and triazines for enhancing cognition as gaba-a-alphas 5 receoptor subtype ligands |
| 02/23/2006 | US20060040936 Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors |
| 02/23/2006 | US20060040935 Method of treating impotence due to spinal cord injury |
| 02/23/2006 | US20060040934 Use of STAT-6 inhibitors as therapeutic agents |
| 02/23/2006 | US20060040930 Novel substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same |
| 02/23/2006 | US20060040916 Carbapenem compound crystals and injection preparations |
| 02/23/2006 | US20060040914 Meso-substituted porphyrins |
| 02/23/2006 | US20060040913 2-Aza-21-carba-5,10,15,20-tetra(3-methoxyphenyl)prophyrin (NC-m-TMPP; for photodynamic therapy, of cancerous and other diseased tissues, Barrett's Oesophagus, ARMD, keratinosis, diabetic neuropathy, peripheral vascular disease, coronary artery disease, disorders arising from bacterial or viral infection |
| 02/23/2006 | US20060040912 Compounds for pdt |
| 02/23/2006 | US20060040906 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 02/23/2006 | CA2577274A1 Anti-inflammatory agents |
| 02/23/2006 | CA2577261A1 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 02/23/2006 | CA2577255A1 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 02/23/2006 | CA2577060A1 Substituted benzofused heterocycles |
| 02/23/2006 | CA2576421A1 Inhibitors of hcv replication |
| 02/23/2006 | CA2575979A1 Novel serotonin receptor ligands and their uses thereof |
| 02/23/2006 | CA2573772A1 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 02/23/2006 | CA2573688A1 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane |
| 02/23/2006 | CA2567782A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/22/2006 | EP1627876A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/22/2006 | EP1626975A2 PROCESS FOR SYNTHESIZING ß-LACTAMASE INHIBITOR IN INTERMEDIATES |
| 02/22/2006 | EP1626973A1 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo 3.2.0]heptane is an effective analgesic agent |
| 02/22/2006 | EP1626972A1 PROCESS FOR SYNTHESIZING ß-LACTAMASE INHIBITOR INTERMEDIATES |
| 02/22/2006 | EP1626971A1 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines |
| 02/22/2006 | EP1626967A1 Substituted pyrazoles |
| 02/22/2006 | EP1456210B1 Pyrazolyl-substituted triazoloquinoxalines |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | EP1224187B1 Certain alkylene diamine-substituted heterocycles |
| 02/22/2006 | CN1738823A Porphyrin derivatives |
| 02/22/2006 | CN1738822A Fungicidal triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing said fungicidal triazolopyrimidines |
| 02/22/2006 | CN1738821A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 02/22/2006 | CN1738814A Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/22/2006 | CN1738625A Benzo (1,2,5) thiadiazole ALS CRF-antagonisten |
| 02/22/2006 | CN1738615A Diaminotriazoles useful as inhibitors of protein kinases |
| 02/21/2006 | US7002021 Diketopyrrolopyrrole pigments |
| 02/21/2006 | US7002009 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H),10-dioxo-2H-1,2,3-triazolo[4,5-c][1]benzazepine; diffraction peaks at diffraction angles in a powder X-ray diffraction pattern; pure, stable crystal |
| 02/21/2006 | US7001914 Compounds |
| 02/21/2006 | US7001911 Fused cyclic modulators of nuclear hormone receptor function |
| 02/21/2006 | US7001910 substituted pyrimidinyl-amino-ethoxy benzyl-thiazolidine-diones; hypoglycemic agents |
| 02/21/2006 | US7001902 Cyclization in presence of Lawesson's reagent |
| 02/21/2006 | US7001900 Central nervous system disorders |
| 02/21/2006 | US7001677 Electroluminescent devices comprising diketopyrrolopyrroles |
| 02/21/2006 | US7001588 Expanded porphyrin compositions for tumor inhibition |
| 02/21/2006 | CA2309340C Pyrimidine derivatives for labeled binding partners |
| 02/16/2006 | WO2006017822A2 Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 02/16/2006 | WO2006017443A2 Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds |
| 02/16/2006 | WO2006017409A2 1,3-disubstituted heteroaryl nmda/nr2b antagonists |
| 02/16/2006 | WO2006017054A2 Tricyclic-heteroaryl compounds useful as kinase inhibitors |
| 02/16/2006 | WO2006016093A1 Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors |
| 02/16/2006 | WO2005121146A3 1, 2, 4-triazolo[1,5a]pyrimidines and use thereof for controlling plant-pathogenic fungi |
| 02/16/2006 | WO2005118544A3 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 02/16/2006 | WO2005110414A3 Hiv integrase inhibitors |
| 02/16/2006 | WO2005097799A8 Pyrazolo`4,3-d! pyrimidines |
| 02/16/2006 | WO2005097107A8 Diphenyl - indol-2-on compounds and their use in the treatment of cancer |
| 02/16/2006 | WO2005080352A3 Quinazoline derivatives and therapeutic use thereof |
| 02/16/2006 | WO2005042475A3 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 02/16/2006 | US20060036093 Pyrimidinone compounds |
| 02/16/2006 | US20060035937 (1S,5S)-3-(5,6-dichloropyridin-3-YL)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate |
| 02/16/2006 | US20060035936 Pain and disorders associated with the nicotinic acetylcholine receptor |
| 02/16/2006 | US20060035912 Pyrrolopyrimidine derivatives useful in cancer treatment |
| 02/16/2006 | US20060035910 Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 02/16/2006 | US20060035909 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout |
| 02/16/2006 | US20060035899 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein |
| 02/16/2006 | US20060035898 morpholin-4-yl-{3-[3-(1H-pyrazol-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl-phenyl}-methanone; FMS-like tyrosine kinase 3 (FLT3), is implicated in cancers, including leukemia, such as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplasia |
| 02/16/2006 | US20060035891 (1S, 2R)-N4-(2-Aminocarbonylcyclopent-1-yl)-5-fluoro-N2-[4-(4-methylpiperazin-1-yl)-3-methylphenyl]-2,4-pyrimidinediamine, having antiproliferative activity, used to inhibit cellular proliferation and to treat proliferate diseases such as cancers |
| 02/16/2006 | US20060035886 Process for preparing pyrrolotriazine aniline compounds useful as kinase inhibitors |
| 02/16/2006 | US20060035885 8-Substituted-6,7,8,9-tetrahydropyrimido [1,2-a] pyrimidin-4-one derivatives |
| 02/16/2006 | US20060035883 Novel serotonin receptor ligands and their uses thereof |
| 02/16/2006 | US20060035876 Combination therapy of an SODm and a corticosteroid for prevention and/or treatment of inflammatory bone or joint disease |
| 02/16/2006 | DE102004033405A1 New 7-phenylamino-quinolone or 1,8-naphthyridone derivatives, useful e.g. for treating type II diabetes or arteriosclerosis, are inhibitors of glycogen phosphorylase |
| 02/16/2006 | CA2576949A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 02/16/2006 | CA2575808A1 Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds |
| 02/16/2006 | CA2575430A1 1,3-disubstituted heteroaryl nmda/nr2b antagonists |
| 02/16/2006 | CA2573848A1 Constrained cyano compounds |
| 02/15/2006 | EP1625847A1 Pharmaceutical composition comprising a tetrahydrotriazolo[4,3-a]pyrazine |
| 02/15/2006 | EP1625131A1 Process and apparatus for preparing metal or nonmetal phthalocyanine |
| 02/15/2006 | EP1625130A2 Hiv integrase inhibitors |
| 02/15/2006 | EP1625129A1 Heterocyclyl-substituted dihydroquinazolines and use thereof as an antiviral agent |
| 02/15/2006 | EP1625116A1 Process for the preparation of carbostyril derivatives,such as aripiprazole and its intermediates |
| 02/15/2006 | EP1624935A2 Anti-adhesion composites and methods os use thereof |
| 02/15/2006 | EP1624874A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/15/2006 | EP1453835B1 Adenosine a 2a receptor antagonists |
| 02/15/2006 | CN1735616A Pyrrolobenzodiazepines |
| 02/15/2006 | CN1735615A Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 02/15/2006 | CN1735614A Pyrazolopyrimidines as cyclin-dependent kinase inhibitors |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1242511C Electrolytic solution for secondary battery and secondary battery including the same |
| 02/15/2006 | CN1241925C New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them |
| 02/15/2006 | CN1241924C Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
| 02/14/2006 | US6998487 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties |
| 02/14/2006 | US6998485 3a,8a-Bis-azidomethyl-3a,4,8a,9-tetrahydro-3H,8H-bis[1,2,3]triazolo[1,5-a;1'',5''-d]pyrazine; provides low molecular weight energetic compounds with multiple energetic groups |
| 02/14/2006 | US6998483 improves yields by avoiding the use of chlorosulphonic acid so no imidazotriazinonesulphonyl chlorides are formed as intermediates ; 4-ethoxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazol[5,1-fl-[1,2,4]triazin-2-yl)benzenesulphonic acid |
| 02/14/2006 | US6998402 7-(1-Acetylpentyl)-5-methyl-2-(4-methylbenzyl)imidazo[5,1-f][1,2,4]triazin-4(3H)-one; learning enhancement, concentration power, learning power, memory power; enzyme inhibitors of phosphodiesterase isoenzyme |